Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 27, 2020Current Pharmaceutical Design

Peripheral Artery Disease in Diabetes Mellitus: Focus on Novel Treatment Options

View Full Paper
Ask AI
Bookmark
Share

Why the study?

DM and PAD share pathophysiological pathways, and emerging data on agents targeting these pathways along with the pleiotropic effects of novel glucose-lowering drugs warrant summary.

Design

Review

Authors

ADAndrea DemarchiASAlberto SomaschiniSCStefano Cornara

Discussion

Loading...

Member takes

Overview

May inform comorbid DM-PAD management; leaves open confirmation of pleiotropic benefits in randomized trials.

Structured PICO

P
Population
Patients with Diabetes Mellitus (DM) and Peripheral Artery Disease (PAD)
I
Intervention
Novel treatment options, including agents targeting shared pathophysiological pathways and novel glucose-lowering drugs

This review highlights emerging medical and interventional approaches, including novel glucose-lowering drugs, for managing peripheral artery disease in patients with diabetes mellitus.

Cite This Study

Demarchi et al. (2020) studied this question.

synapsesocial.com/papers/6a72c2e25d37378ac1df68f9https://doi.org/10.2174/1389201021666201126143217
View Full Paper
Ask AI
Bookmark
Share